Literature DB >> 8624095

Alzheimer's disease and apolipoprotein E in Italy.

S Sorbi1, B Nacmias, P Forleo, S Piacentini, L Amaducci.   

Abstract

Recent studies have provided evidence of association of apolipoprotein E (ApoE) epsilon 4 allele and late onset familial and sporadic Alzheimer's disease (AD). Epidemiological studies have established allelic variation at the ApoE locus. We have analyzed the ApoE gene polymorphism in a sample of 416 Italian subjects. Our data confirm a significant association between epsilon 4 allele and sporadic AD. The frequency of epsilon 4 allele in early onset familial AD patients was comparable to control values suggesting that epsilon 4 allele does not represent a risk factor for early onset familial AD (EOFAD). Moreover, we found a not-previously reported association between ApoE epsilon 2 allele and sporadic AD and EOFAD. We included in this study two EOFAD families with the APP717 Val-->Ile mutation in the Amyloid Precursor Protein (APP) gene on chromosome 21. In any of the EOFAD families there was a significant effect of the ApoE genotype on the age of onset with the exception of one of the two mutated EOFAD families in which the 2 allele delays the age of onset.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624095     DOI: 10.1111/j.1749-6632.1996.tb34429.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve.

Authors:  L Mosconi; K Herholz; I Prohovnik; B Nacmias; M T R De Cristofaro; M Fayyaz; L Bracco; S Sorbi; A Pupi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

2.  Education and occupation provide reserve in both ApoE ε4 carrier and noncarrier patients with probable Alzheimer's disease.

Authors:  V Garibotto; B Borroni; S Sorbi; S F Cappa; A Padovani; D Perani
Journal:  Neurol Sci       Date:  2011-12-16       Impact factor: 3.307

3.  Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease.

Authors:  L Mosconi; B Nacmias; S Sorbi; M T R De Cristofaro; M Fayazz; A Tedde; L Bracco; K Herholz; A Pupi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

Review 4.  Genetic Heterogeneity of Alzheimer's Disease: Embracing Research Partnerships.

Authors:  Benedetta Nacmias; Silvia Bagnoli; Irene Piaceri; Sandro Sorbi
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.